End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.084 AUD | -1.18% | -5.62% | +42.37% |
Jun. 03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Neutral |
Resistance | 0.0890 | 0.0960 | 0.0960 |
Spread/Res. | -5.62% | -12.50% | -12.50% |
Spread/Supp. | +5.00% | +61.54% | +64.71% |
Support | 0.0800 | 0.0520 | 0.0510 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PER Stock
- Charts Percheron Therapeutics Limited